ERIN KOSAK: Open Payments
NPI 1003276676 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$206 in 6 payments from 5 companies in 2025. Trend: 2023 $45 · 2024 $94 · 2025 $206
Food & beverage: $206
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $105 |
| Novo Nordisk Inc | 2 | $36 |
| Dexcom, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $20 |
| Antares Pharma, Inc. | 1 | $19 |
Products named: XIFAXAN, Wegovy, Dexcom G6 Transmitter, MOUNJARO, XYOSTED.
Industry payments across SC — which companies pay providers there.
